TY - JOUR
T1 - Preferential activation of circulating CD8+ and γδ T cells in patients with active Behçet's disease and HLA-B51
AU - Yasuoka, Hidekata
AU - Yamaguchi, Yukie
AU - Mizuki, Nobuhisa
AU - Nishida, Tomomi
AU - Kawakami, Yutaka
AU - Kuwana, Masataka
PY - 2008/7/1
Y1 - 2008/7/1
N2 - Objective. To evaluate the activation status of circulating CD4+, CD8+, and γδ T cells in patients with active and inactive Behçet's disease (BD). Methods. We studied 11 subjects with active BD, 28 with inactive BD, and 13 healthy controls. The expression of CD4, CD8, pan-γd, Vδ1, and Vδ2 along with the early activation marker CD69 was analyzed by 3-color flow cytometry. Results. Proportions of activated CD8+ and γδ T cells were significantly greater in patients with active BD than in those with inactive BD or healthy control subjects, but the proportion of activated CD4+ T cells did not differ among these 3 groups. In addition, significantly greater proportions of the Vδ1+ and Vδ2+ γδ T-cell subsets were activated in patients with active BD than in those with inactive BD or healthy controls; in active BD, the balance of activation between these subsets favored the Vδ1+ T cells. No significant differences in these proportions were found between subjects with inactive BD and healthy controls. These findings were observed exclusively in patients with HLA-B51. A comparison of samples from 5 patients taken during active BD and after resolution of BD-related symptoms showed the proportions of activated CD8+ and γδ T cells dropped when the patients' BD became inactive. Conclusion. CD8+ and γδ T cells, rather than CD4+ T cells, were activated in vivo in patients with active BD and HLA-B51, but not in those with inactive BD, suggesting that these potentially cytotoxic T cells play a critical role in BD flares.
AB - Objective. To evaluate the activation status of circulating CD4+, CD8+, and γδ T cells in patients with active and inactive Behçet's disease (BD). Methods. We studied 11 subjects with active BD, 28 with inactive BD, and 13 healthy controls. The expression of CD4, CD8, pan-γd, Vδ1, and Vδ2 along with the early activation marker CD69 was analyzed by 3-color flow cytometry. Results. Proportions of activated CD8+ and γδ T cells were significantly greater in patients with active BD than in those with inactive BD or healthy control subjects, but the proportion of activated CD4+ T cells did not differ among these 3 groups. In addition, significantly greater proportions of the Vδ1+ and Vδ2+ γδ T-cell subsets were activated in patients with active BD than in those with inactive BD or healthy controls; in active BD, the balance of activation between these subsets favored the Vδ1+ T cells. No significant differences in these proportions were found between subjects with inactive BD and healthy controls. These findings were observed exclusively in patients with HLA-B51. A comparison of samples from 5 patients taken during active BD and after resolution of BD-related symptoms showed the proportions of activated CD8+ and γδ T cells dropped when the patients' BD became inactive. Conclusion. CD8+ and γδ T cells, rather than CD4+ T cells, were activated in vivo in patients with active BD and HLA-B51, but not in those with inactive BD, suggesting that these potentially cytotoxic T cells play a critical role in BD flares.
KW - Behçet's disease
KW - CD antigens
KW - T lymphocytes
KW - γδ T cells
UR - http://www.scopus.com/inward/record.url?scp=55049087560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55049087560&partnerID=8YFLogxK
M3 - Article
C2 - 19026117
AN - SCOPUS:55049087560
SN - 0392-856X
VL - 26
SP - S59-S63
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
IS - 4 SUPPL. 50
ER -